Skip to main content
. 2012 Jul 17;7(7):e40971. doi: 10.1371/journal.pone.0040971

Table 1. Patient characteristics at ART initiation.

Characteristic N = 1450
Year of ART initiation: n (%)
2005–2006 458 (31.6)
2007 461 (31.8)
2008–2009 531 (36.6)
Gender: n (%)
Male 491 (33.9)
Female 959 (66.1)
Age (years): median (range) 40 (18–74)
Age <40 years: n (%) 680 (46.9)
Age ≥40 years: n (%) 738 (50.9)
Missing: n (%) 32 (2.2)
Civil status: n (%)
Single 194 (13.4)
Married 675 (46.6)
Widowed/divorced 560 (38.6)
Missing 21 (1.4)
Weight (kg): mean (SD) 56.9 (13.6)
Weight <50: n (%) 430 (29.7)
Weight ≥50: n (%) 858 (59.2)
Missing: n (%) 162 (11.2)
CD4 (cells/µL): median (IQR) 150 (71–238)
CD4<50: n (%) 85 (5.9)
CD4≥50<200: n (%) 258 (17.8)
CD4≥200: n (%) 182 (12.6)
Missing: n (%) 925 (63.8)
TLC (cells/µl): median (IQR) 1204 (840–1728)
TLC <1200: n (%) 372 (25.7)
TLC ≥1200: n (%) 74 (5.1)
Missing: n (%) 1,004 (69.2)
Prior ART experience: n (%)
Yes 169 (11.7)
No 1,257 (86.7)
Missing 24 (1.6)
WHO stage at start: n (%)
WHO stage 1–2 247 (17.0)
WHO stage 3 847 (58.4)
WHO stage 4 129 (8.9)
Missing 227 (15.7)
Regimen at initiation: n (%)
D4T-3TC-NVP 1214 (83.7)
ZDV-3TC-NVP 104 (7.2)
D4T-3TC-EFV 76 (5.2)
ZDV-3TC-EFV 51 (3.5)
Other 5 (0.3)
Distance from clinic: n (%)
<1 hour 644 (44.4)
≥1 hour <2 hours 186 (12.8)
≥2 hours 111 (7.7)
Missing 509 (35.1)